From: Etiology of Persistent Microalbuminuria in Nigeria (P_MICRO study): protocol and study design
Visit 1 | Visit 2 (4–8 weeks after Visit 1) |
---|---|
– Screening, informed consent – HIV testing (HIV-negative participants only) – Blood pressure measurement – Diabetes screeninga – Enrollment (if meet eligibility criteria) – Participant to provide urine specimen at study clinic on day of visit (for 1st uACR and for urine albumin-to-protein ratio (uAPR) (if HIV-positive)) | – Participant to provide urine specimen at study clinic on day of visit (for 2nd uACR) – Specimen collection (~ 6 tubes; ~ 30 mL total) i) Genotyping (Two DBS cards) ii) Serum creatinine (3 mL gold top tube) iii) HBVb and HCV testingc (Two 3.5 mL gold top tubes) iv) CMV testingd (One 3.5 mL gold top tube) v) Additional specimens to store (Two urine aliquots: Two 3 mL EDTA tubes; toenail/hair samples from consenting patients) |